{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-22T14%3A10%3A53.393Z&max-questionFirstMinisteriallyCorrected.=2019-07-31T15%3A30%3A59.74Z&registeredInterest=false", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-22T14%3A10%3A53.393Z&max-questionFirstMinisteriallyCorrected.=2019-07-31T15%3A30%3A59.74Z&registeredInterest=false", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-22T14%3A10%3A53.393Z&max-questionFirstMinisteriallyCorrected.=2019-07-31T15%3A30%3A59.74Z&registeredInterest=false&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=0&min-answer.questionFirstAnswered.=2019-05-22T14%3A10%3A53.393Z&max-questionFirstMinisteriallyCorrected.=2019-07-31T15%3A30%3A59.74Z&registeredInterest=false", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-22T14%3A10%3A53.393Z&max-questionFirstMinisteriallyCorrected.=2019-07-31T15%3A30%3A59.74Z&registeredInterest=false", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-22T14%3A10%3A53.393Z&max-questionFirstMinisteriallyCorrected.=2019-07-31T15%3A30%3A59.74Z&registeredInterest=false", "items" : [{"_about" : "http://data.parliament.uk/resources/1132035", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1132035/answer", "answerText" : {"_value" : "<p><ins class=\"ministerial\"> <p><ins class=\"ministerial\">Primary Care Networks (PCNs) are a new way for primary and community service organisations to work together. For PCNs to be successful they will need to work in partnership with local people and the communities they serve. Legal duties which currently apply to NHS service providers - including general practitioner practices - and commissioners around engagement and consultation will continue to be valid for PCNs.<\/ins><\/p><\/ins><\/p><p><del class=\"ministerial\">NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a \u2019commercial framework\u2019 setting out the parameters for the commercial approach for medicines in the health service in England.<\/del><\/p><p><del class=\"ministerial\">The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.<\/del><\/p><p><del class=\"ministerial\">In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.<\/del><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-06-18", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1132035/answer/previousversion/123829", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
          }
          , "answeringMemberConstituency" : {"_value" : "South Ribble"}
          , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        }
        , "questionFirstAnswered" : [{"_value" : "2019-06-18T16:34:05.507Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2019-06-19T08:36:30.617Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-06-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Primary Care Networks"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the requirements for primary care networks to engage with the local community will be.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4249", "label" : {"_value" : "Biography information for Anne Marie Morris"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newton Abbot"}
      , "tablingMemberPrinted" : [{"_value" : "Anne Marie Morris"}
      ], "uin" : "264406"}
    , {"_about" : "http://data.parliament.uk/resources/1129191", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1129191/answer", "answerText" : {"_value" : "<p>Information on the number of prescription items from the Prescription Cost Analysis system for benzodiazepines and antidepressants written in the United Kingdom and dispensed in the community in England, for the year 2018 can be found in the attached tables.<\/p><p>The data available is at prescription item level by presentation. Prescriptions are prescribed either by a paper prescription form or via an Electronic Prescription Service message. Each single item written on the form is counted as a prescription item. No information is available for those prescriptions written but not dispensed.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1129191/answer/attachment/1", "fileName" : {"_value" : "PQ259400 table formatted.docx"}
          , "title" : "Prescription data benzodiazipines & antidepressant"}
        , "dateOfAnswer" : {"_value" : "2019-06-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1129191/answer/previousversion/122124", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
          }
          , "answeringMemberConstituency" : {"_value" : "South Ribble"}
          , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        }
        , "questionFirstAnswered" : [{"_value" : "2019-06-11T16:51:00.313Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2019-06-12T14:34:05.54Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-06-03", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescription Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many prescriptions of (a) individual benzodiazepine drugs and (b) individual antidepressants were dispensed in the community in 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4621", "label" : {"_value" : "Biography information for Darren Jones"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bristol North West"}
      , "tablingMemberPrinted" : [{"_value" : "Darren Jones"}
      ], "uin" : "259400"}
    , {"_about" : "http://data.parliament.uk/resources/1128442", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1128442/answer", "answerText" : {"_value" : "<p><ins class=\"ministerial\"> <p><ins class=\"ministerial\">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.<\/ins><\/p><p><ins class=\"ministerial\">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.<\/ins><\/p><p><ins class=\"ministerial\">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.<\/ins><\/p><\/ins><\/p><p><del class=\"ministerial\">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:<\/del><\/p><p><del class=\"ministerial\"><a href=\"http://www.legislation.gov.uk/uksi/2018/1055/impacts\" target=\"_blank\">http://www.legislation.gov.uk/uksi/2018/1055/impacts<\/a><\/del><\/p><p><del class=\"ministerial\">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.<\/del><\/p><p><del class=\"ministerial\">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:<\/del><\/p><p><del class=\"ministerial\"><a href=\"https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf\" target=\"_blank\">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf<\/a><\/del><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-06-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1128442/answer/previousversion/121340", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
          }
          , "answeringMemberConstituency" : {"_value" : "South Ribble"}
          , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        }
        , "questionFirstAnswered" : [{"_value" : "2019-06-10T13:18:03.37Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2019-06-11T11:31:21.83Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-05-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
      , "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
      ], "uin" : "257706"}
    , {"_about" : "http://data.parliament.uk/resources/1126321", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1126321/answer", "answerText" : {"_value" : "<p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.<\/p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.<\/p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class=\"ministerial\">on the blocker and cross-sex hormones, for those who were appropriate for this, as<\/ins><del class=\"ministerial\">once<\/del> all of the young people in the study have reached <ins class=\"ministerial\">this<\/ins><del class=\"ministerial\">the<\/del> stage<ins class=\"ministerial\">.<\/ins> <del class=\"ministerial\">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.<\/del><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-05-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1126321/answer/previousversion/119577", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
          }
          , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        }
        , "questionFirstAnswered" : [{"_value" : "2019-05-22T14:51:30.447Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2019-07-31T15:30:59.74Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Gender Dysphoria: Children"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1879", "label" : {"_value" : "Biography information for Lord Lucas"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Lucas"}
      ], "uin" : "HL15681"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 4, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}